Case conference March, 28th 2012
29-Mar-2012, Divisi Ginekologi Onkologi RSCMOncology case conference march 25th 2012
Mrs. Siti N, 49 yo
Post optimal debulking + 3x NAC and 3x adjuvant chemoth (carboplatin+paclitaxel) due to ovarian cancer (clear cell) advance stage
• CC: bring lab result (Ca125 119)
• 8/5/11: came with cystic ovarian neoplasm susp malignancy (Ca 125 354.9)
• 19/5/11:Cytology ascitesà adenocarcinoma
• 8/6 until 28/7/2011:Chemoth/CP 3x, Ca 125 40.7
• 28/9/11: post NAC 3 series,
– Stable disease
– Resectable (+), plan for laparotomy
• 10/11/11: optimal debulking (TAH BSO, total omentectomy, right paracolic peritonectomy, tumor implant excision, appendectomy)
• 22/11/11: PA result shows clear cell carcinoma with poor differentiation
• 18/1/12: change chemoth/ with carbo-paclitaxel 3 series (25/1 until 7/3)
Physical exam
Compos mentis
BP 120/70 mmHg Pulse 89x/min
RR 18x/min T 36.8
• Conjunctiva : not anemic
• Heart/lung : wnl
• Abdomen : wnl
• Extremities : edema -/-
Gynecological status
• Inspection : wnl
• Inspeculo : smooth vaginal stump, no mass
• VRE :smooth vaginal stump, no palpable mass, TSMA wnl
US May 13 2011 (before NAC)
- Anteflexed uterus with multiple intramural myoma size 28-38 mm. Regular endometrium.
- Cystic mass on right adnexa with solid part, irregular shape and border, RI 0.28 could be originated from right ovarian neoplasm
- Normal left ovary
- Liver, spleen and both kidney normal
- Ascites (+)
Conclusion :
Ascites and cystic mass with solid part of the right ovary, suspected malignancy
US August 22 2012( post NAC 3 series)
- anteflexed uterus with multiple intramural and subserous myoma size 27-46 mm. Regular endometrium.
- right adnexa : cystic mass with solid part, regular size and shape, size 182x110x184 mm (vol~1950 cc), neovascularization (+) RI 0.37 ~ right ovarian neoplasm.
- Normal left ovary.
- Ascites (-).
- Normal liver, spleen, both kidney and bladder.
Conclusion :
- Intramural and subserous myoma
- Cystic neoplasm with solid part suspected malignancy (from previous ultrasound, mass volume is getting bigger).
US March 20 2012 (post Adjuvant chemotherapy 3x)
• Conclusion: no new mass visualized
Ca 125 (March, 21 2012) : 119
Diagnosis
• Post optimal debulking + 3x NAC and 3x adjuvant chemoth (carboplatin+paclitaxel) due to ovarian cancer (clear cell) advance stage
Problem
• Post optimal debulking + 3x NAC and 3x adjuvant chemoth (carboplatin+paclitaxel) due to ovarian cancer (clear cell) advance stage, complete response
• Increased ca 125 level ( 119) and no mass on US
Plan
• Continue chemotherapy 3 series or observation??
Berita Lainnya
13-Mar-2013,Divisi Ginekologi Onkologi RSCMCase Conference March 13th 2013

Case Conference March 13th 2013

Case Conference March 6th 2013

Case Conference March 6th 2013

Case Conference February 20th 2013

Case Conference February 113th 2013

Case Conference February 6th 2013

Case Conference February 6th 2013

Case Conference February 6th 2013

Case Conference February 6th 2013

